Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations

• Daniel Y C Heng,
• Kosuke Takemura

Affiliations

Daniel Y C Heng

Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada

Kosuke Takemura

Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan